The Food and Drug Administration (FDA) is announcing a regional public meeting entitled ‘‘Health Canada and United States Food and Drug Administration Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Human Use (ICH)’’ to provide information and receive comments on the current activities of ICH as well as the upcoming meetings in Amsterdam, Netherlands, in June 2019. The topics to be discussed are the topics for discussion at the forthcoming ICH Assembly Meeting. The purpose of the public meeting is to solicit public input prior to the next ICH Assembly meeting and the expert working groups meetings in Amsterdam, Netherlands, scheduled for June 1 through 6, 2019, at which the discussion of the topics underway will continue.
April 29, 2019
10:00 a.m. to 1:00 p.m. ET
10903 New Hampshire Ave. Bldg 31 Conference Center, Rm. 1503 (Great Room) Silver Spring, MD 20993, USA Or Webcast (A website to access the webcast will be emailed to those who register for the meeting as a remote attendee – see Registration for details)
Webcast (A website to access the webcast will be emailed to those who register for the meeting as a remote attendee – see Registration for details)
For more information: please contact William Lewallen, William.Lewallen@fda.hhs.gov